Year: 2004
Type: article
Abstract: Much remains unknown of the phylogeny and evolution of Mycobacterium tuberculosis, an organism that kills 2 million people annually.Using a population-based approach that analyzes multiple loci around the chromosome, we demonstrate that neutral genetic variation in genes associated with antimicrobial drug resistance has sufficient variation to construct a robust phylogenetic tree for M. tuberculosis.The data describe a clonal population with a minimum of four distinct M. tuberculosis lineages, closely related to M. bovis.The lineages are strongly geographically associated.Nucleotide substitutions proven to cause drug resistance are distributed throughout the tree, whereas nonsynonymous base substitutions unrelated to drug resistance have a restricted distribution.The phylogenetic structure is concordant with all the previously described genotypic and phenotypic groupings of M. tuberculosis strains and provides a unifying framework for both epidemiologic and evolutionary analysis of M. tuberculosis populations.M ycobacterium tuberculosis has caused tuberculosis (TB) in humans for thousands of years (1,2), and the World Health Organization (WHO) estimates that one third of the global population is infected with M. tuberculosis (3); however, the bacterium has remained an enigma.The global resurgence of TB highlights the need for an improved understanding of its epidemiology and its evolutionary biologic features.Recent advances in molecular characterization of M. tuberculosis isolates, which index variation in insertion sequences (4) and repetitive genomic elements (5,6), have elucidated clusters of identical and closely related strain families (7-9).These findings have provided insights into regional (10) and national (11) epidemiologic features.However, these techniques may be less suited to global population and evolutionary analyses, and integrating information obtained from different approaches is complex (12).Genomic comparisons have identified genetic variation for population screening; however, these analyses are limited to those sites that vary between the compared genomes and are potentially misleading (13-15).Nucleotide sequences provide robust, portable, and comparable data for studying population variation.The mutational processes that generate this variation are understood, and sequence data have been successfully used in the study of bacterial epidemiology, population biology, and evolution ( 16).The complete genome sequences (15-18) provide access to all regions of the chromosome and facilitate such studies.However, high-throughput gene sequencing of structural genes (19) and host immune system protein targets (20) in M. tuberculosis isolates indicated low levels of sequence diversity.Although extensive genomic sequencing was performed in both studies, comparable sequence data were obtained on a limited number of highly selected isolates.We used an unbiased population approach to analyze genetically silent nucleotide sequence variation for seven unlinked loci distributed around the chromosome.The loci chosen were genes associated with antimicrobial drug resistance that have been reported to possess >95% of all sequence variation observed in 26 structural genes studied (19), which includes >90% of synonymous nucleotide substitutions, i.e., nucleotide substitutions that do not affect the translated amino acid.In a population sample of 316 U.K. clinical isolates, silent single nucleotide polymorphisms (sSNPs) resolve an unambiguous phylogeny and provide a unifying framework for epidemiologic, population, and evolutionary analyses. Methods Bacterial StrainsThe 316 M. tuberculosis clinical isolates were identified in England and Wales from January 1, 1998, through
Source: Emerging infectious diseases
Institutions: Health Protection Agency, University of Oxford
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W1969464199
